Posterior Segment Company Updates episode artwork

EPISODE · Oct 30, 2024 · 7 MIN

Posterior Segment Company Updates

from Eyewire News: The Podcast · host Eyewire News

Several companies with product candidates in the posterior segment provide updates; Ocuphire acquires an ophthalmic gene therapy company; and Astellas provides an update on its regulatory plans for GA drug avacincaptad pegol. Learn more about your ad choices. Visit megaphone.fm/adchoices

NOW PLAYING

Posterior Segment Company Updates

0:00 7:08

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Eyewire News: The Podcast?

This episode is 7 minutes long.

When was this Eyewire News: The Podcast episode published?

This episode was published on October 30, 2024.

What is this episode about?

Several companies with product candidates in the posterior segment provide updates; Ocuphire acquires an ophthalmic gene therapy company; and Astellas provides an update on its regulatory plans for GA drug avacincaptad pegol. Learn more about your...

Can I download this Eyewire News: The Podcast episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!